WEKO3
インデックスリンク
アイテム
メサラジン坐薬調製の工夫と臨床経験(発表論文抄録(2013))
https://fukuyama-u.repo.nii.ac.jp/records/8749
https://fukuyama-u.repo.nii.ac.jp/records/8749e8839e4a-74c0-4579-9472-bb16976bab9d
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
船隠恵子(発表論文抄録(2013)) (119.2 kB)
|
Copyright (c) 2014 by Fukuyama University
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2017-12-19 | |||||
| タイトル | ||||||
| タイトル | メサラジン坐薬調製の工夫と臨床経験(発表論文抄録(2013)) | |||||
| タイトル | ||||||
| タイトル | Mesalazine suppositories and their clinical application | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | jpn | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | メサラジン坐薬 | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | 潰瘍性大腸炎直腸型 | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | mesalazine suppositories | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | ulcerative proctitis | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | departmental bulletin paper | |||||
| 著者 |
船隠, 恵子
× 船隠, 恵子× 堀田, 修次× 濱岡, 照隆× 田阪, 武志× 立花, 広志× 村上, 敬子× 豊川, 達也× 佐藤, 英治× 友田, 純 |
|||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45735 | |||||
| 姓名 | Funagakure, Keiko | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45736 | |||||
| 姓名 | Horita, Syuzi | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45737 | |||||
| 姓名 | Hamaoka, Terutaka | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45738 | |||||
| 姓名 | Tasaka, Takeshi | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45739 | |||||
| 姓名 | Tatibana, Hiroshi | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45740 | |||||
| 姓名 | Murakami, Takako | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45741 | |||||
| 姓名 | Toyokawa, Tatuya | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45742 | |||||
| 姓名 | Sato, Eiji | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 45743 | |||||
| 姓名 | Tomoda, Jun | |||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Ulcerative proctitis (UP) is a prevalent condition associated with increased morbidity, and topical mesalazine (5-aminosalicylic acid [5-ASA]) is known to inhibit the inflammatory processes in UP. We successfully devised mesalazine suppositories, in which 250mg mesalazine was equally distributed and remained stable for at least 2 weeks. We evaluated the effect of using mesalazine suppositories twice a day (BID) on two UP patients. The results demonstrated that mesalazine suppositories were efficacious, well tolerated and safe for the long-term maintenance of UP remission. | |||||
| 内容記述 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Ulcerative proctitis (UP) is a prevalent condition associated with increased morbidity, and topical mesalazine (5-aminosalicylic acid [5-ASA]) is known to inhibit the inflammatory processes in UP. We successfully devised mesalazine suppositories, in which 250mg mesalazine was equally distributed and remained stable for at least 2 weeks. We evaluated the effect of using mesalazine suppositories twice a day (BID) on two UP patients. The results demonstrated that mesalazine suppositories were efficacious, well tolerated and safe for the long-term maintenance of UP remission. | |||||
| 書誌情報 |
福山大学薬学部研究年報 en : Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University 号 32, p. 41-41, 発行日 2014-12-25 |
|||||
| 出版者 | ||||||
| 出版者 | 福山大学薬学部 | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0288-724X | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AN10064550 | |||||
